There were, at that point, about a hundred and 90 odd different vaccine candidates at different stages of development. And the response from the experts was it was about 15 % for those vaccines that were already in clinical iles. If vacines weren't yet in the clinic, it was probably a ten% chance of success. So i did my normal sort of, why me am and surely that you've got somebody better that could do this. But then on the third meeting i joined, i then get a text during that meeting. I'm from hancock, and i just am not used to all this. This is how government works as they text each other. It certainly felt quite a
Kate Bingham is the former Chair of the UK Vaccine Taskforce and she's also a shrewd business mind, having been a successful venture capitalist in sectors such as biotech for the past 30 years. She recently spoke with Jessica Pulay at the Cliveden Literary Festival to discuss how business acumen played its part in managing a team of experts from sectors such as science, medicine, industry and academia, in the race to find vaccines to combat the COVID-19 pandemic.
Learn more about your ad choices. Visit podcastchoices.com/adchoices